Italy – Antineoplastic and immunomodulating agents – GARA EUROPEA A PROCEDURA APERTA PER LA FORNITURA, IN ACCORDO QUADRO MULTIFORNITORE, DI PRINCIPI ATTIVI PER TERAPIE CON CELLULE CAR-T DESTINATE A PAZIENTI IN CARICO ALL’AZIENDA ULSS N. 8 BERICA
Opportunity Score
Confidence: 55%
Complexity: high
21 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open EU procedure for a multi-supplier framework agreement for the supply of active principles for CAR-T cell therapies to patients under Azienda ULSS N. 8 Berica. The tender is divided into 3 lots covering different lymphoma indications, with a total estimated value of €19,401,945. Submission is electronic via the Sintel platform, and the deadline is 26 July 2026. Award is based on price only. No procurement documents were analyzed; only the TED notice and structured data are available.
Strengths
Documents available
Open procedure
21 days left
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Registration on the Sintel electronic platform (ARIA SPA).
- Electronic submission only via Sintel.
- All documents and communication in Italian.
Buyer
Name
AZIENDA ULSS N. 8 BERICA
Location
VICENZA, ITA
Buyer profile
Identifier
02441500242
Lots (3)
Therapy for adult patients with DLBCL (2nd line) and PMBCL (3rd line).
Therapy for adult patients with DLBCL (3rd line).
Therapy for adult patients with follicular lymphoma (4th line).
Procurement Details
Publication
28 May 2026
Deadline
06 Jul 2026, 10:00
Procedure
open
Contract
supplies
Duration
12 MONTH
Language
ITA
Publication #
370198-2026
Classification
Performance: Italy
Documents (2)
Opportunity Score
Confidence: 55%
Complexity: high
21 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation